4-(((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)amino)-6-methoxy-2-methylquinazolin-7-yl (2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)carbamate

ID: ALA5275656

Max Phase: Preclinical

Molecular Formula: C33H30F3N7O6

Molecular Weight: 677.64

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)nc(C)nc2cc1OC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O

Standard InChI:  InChI=1S/C33H30F3N7O6/c1-15(17-9-18(33(34,35)36)11-19(37)10-17)38-29-21-12-26(48-3)27(13-24(21)39-16(2)40-29)49-32(47)41-23-6-4-5-20-22(23)14-43(31(20)46)25-7-8-28(44)42-30(25)45/h4-6,9-13,15,25H,7-8,14,37H2,1-3H3,(H,41,47)(H,38,39,40)(H,42,44,45)/t15-,25?/m1/s1

Standard InChI Key:  MQIPNVKKSWBKOW-FXBVVIMESA-N

Molfile:  

 
     RDKit          2D

 49 54  0  0  0  0  0  0  0  0999 V2000
   -3.3529    4.3286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6383    3.9163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9238    4.3561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2092    3.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1816    3.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8688    2.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6109    3.0918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8413    1.8826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5559    1.4428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1268    1.4978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0993    0.6733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7864    0.2336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7589   -0.5908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4734   -1.0031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0443   -0.9756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3297   -0.5359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572    0.2885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3298    0.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0443    0.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7589    0.7831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4735    0.3710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0718   -0.4809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3847   -0.9206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8139   -0.8657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8413   -1.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1268   -2.1299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5559   -2.1024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5834   -2.9269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3254   -3.3117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3529   -4.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6384   -4.5483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9238   -4.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8963   -3.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0993   -3.1193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6321   -3.8064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1543   -4.4660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9069   -5.2356    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1923   -3.8339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770   -4.5483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4016   -4.5759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8413   -3.8888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4565   -3.1468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6321   -3.1193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2473   -2.4047    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6658   -3.9163    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4946    4.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1923    4.8507    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5221    5.2356    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2198    4.0263    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  7  1  0
  7  6  2  0
  6  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 16 15  2  0
 11 17  2  0
 17 16  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 16 23  1  0
 23 22  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 28 33  1  0
 33 32  2  0
 33 34  1  0
 34 35  1  0
 32 36  1  0
 36 35  1  0
 36 37  2  0
 35 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 42 41  1  0
 38 43  1  0
 43 42  1  0
 43 44  2  0
 41 45  2  0
  4 46  1  0
 46 47  1  0
 46 48  1  0
 46 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5275656

    ---

Associated Targets(Human)

SOS1 Tchem Cereblon/SOS1 (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 677.64Molecular Weight (Monoisotopic): 677.2210AlogP: 5.09#Rotatable Bonds: 7
Polar Surface Area: 177.87Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.56CX Basic pKa: 6.55CX LogP: 3.86CX LogD: 3.80
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.15Np Likeness Score: -0.73

References

1. Bian Y, Alem D, Beato F, Hogenson TL, Yang X, Jiang K, Cai J, Ma WW, Fernandez-Zapico M, Tan AC, Lawrence NJ, Fleming JB, Yuan Y, Xie H..  (2022)  Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer.,  65  (24.0): [PMID:36459180] [10.1021/acs.jmedchem.2c01300]

Source